- Global Pharma News & Resources

Reuters Events Cell & Gene Therapy USA 2021 is a virtual meeting taking place on Sept. 28-29 in EST. The event will unite over 1500 stakeholders, involved in commercializing cell and gene therapies, and is free for pharma, biotech and payer organizations to attend.  

The program is built for senior-level execs developing launch plans, leading manufacturing, supply and delivery network readiness and scale up, forging pricing and payment models, and determining policy and value. 

Expert speaker include: 

  • Suneet Varma, Global President, Rare Disease, Pfizer 
  • Kristen Hege, SVP Early Clinical Development, Hematology/Oncology & Cell Therapy, BMS 
  • Stefan Hendriks, Global Head, Cell & Gene, Novartis 
  • Debbie Drane, SVP, Global Commercial Development, CSL Behring 
  • Paul Granadillo, SVP Global Supply Chain, Moderna 
  • Peter Marks, Director, Center for Biologics Evaluation and Research (CBER), FDA 
  • Rita Johnson-Greene, VP, Sales and Qualified Treatment Centers (QTCs), bluebird bio 
  • Lung-I Cheng, Head of Global Value & Access, Cell Therapies, Takeda